Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2026-04-24 @ 5:56 PM
Study NCT ID:
NCT06681402
Status:
RECRUITING
Last Update Posted:
2025-04-27
First Post:
2024-10-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Single-blind Clinical Trial to Evaluate the Safety and Local Immune Activation of a Toll-like Receptor 5 Agonist (FLAMOD) Administered by Aerosol
Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Organization: